Annual report pursuant to Section 13 and 15(d)

STOCK-BASED COMPENSATION ( Stock Option Activity) (Details)

v3.22.4
STOCK-BASED COMPENSATION ( Stock Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Employees    
Number of options    
Outstanding at the beginning of the period (in shares) 11,122,648  
Transfer between employee and consultant (in shares) 40,118  
Granted (in shares) 2,105,258  
Granted in acquisition (in shares) 949,893  
Forfeited (in shares) (355,998)  
Expired (in shares) (26,089)  
Exercised (in shares) (3,149,387)  
Outstanding at the end of the period (in shares) 10,686,443 11,122,648
Exercisable options at the end of the period (in shares) 6,687,488  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Outstanding at the beginning of the period (in USD per share) $ 0.82  
Transfer between employee and consultant (in USD per share) 0.64  
Granted (in USD per share) 2.10  
Granted in acquisition (in USD per share) 0.31  
Forfeited (in USD per share) 1.60  
Expired (in USD per share) 1.37  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 1.15 $ 0.82
Exercisable exercise price at the end of the period (in USD per share) $ 0.75  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 6 years 10 months 6 days 6 years 10 months 13 days
Outstanding exercisable, weighted average remaining contractual term (in years) 5 years 9 months 7 days  
Outstanding intrinsic value at the beginning of the period $ 64,818  
Outstanding intrinsic value at the end of the period 5,923 $ 64,818
Outstanding exercisable intrinsic value at the end of the period $ 6,409  
Consultants    
Number of options    
Outstanding at the beginning of the period (in shares) 179,627  
Transfer between employee and consultant (in shares) 40,118  
Granted (in shares) 0  
Forfeited (in shares) (460)  
Expired (in shares) (209)  
Exercised (in shares) (69,298)  
Outstanding at the end of the period (in shares) 69,542 179,627
Exercisable options at the end of the period (in shares) 64,524  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]    
Outstanding at the beginning of the period (in USD per share) $ 0.31  
Transfer between employee and consultant (in USD per share) 0.64  
Granted (in USD per share) 0  
Forfeited (in USD per share) 2.81  
Expired (in USD per share) 2.81  
Exercised (in USD per share) 0.30  
Outstanding at the end of the period (in USD per share) 0.47 $ 0.31
Exercisable exercise price at the end of the period (in USD per share) $ 0.46  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures    
Outstanding option, weighted average remaining contractual term (in years) 4 years 2 months 15 days 2 years 4 months 2 days
Outstanding exercisable, weighted average remaining contractual term (in years) 3 years 11 months 4 days  
Outstanding intrinsic value at the beginning of the period $ 1,139  
Outstanding intrinsic value at the end of the period 86 $ 1,139
Outstanding exercisable intrinsic value at the end of the period $ 81